ADMA Biologics Soars to All-Time High Following FDA Approval for Production Enhancement
ADMA Biologics Inc. reached an all-time high of $24.02 on April 28, 2025, driven by FDA approval for a production yield enhancement process and investor confidence in its growth potential.
2 minutes to read